The American Society of Clinical Oncology reported a study of 80,000 women in 70 clinical trials. The object of the study was to determine the affect of obesity on breast cancer survival. Researchers differentiated between pre- and post-menopausal women, type of cancer (ER+ or ER-), tumor size, lymph node involvement and treatment regimens to isolate the effects of BMI on mortality. Previous studies have already linked obesity with a greater risk of developing cancer. The results showed that death rates were significantly higher for premenopausal obese women with estrogen-receoptor (ER+) breast cancer.
Source: Chemotherapyadvisor
Robert G. Tupac, DDS, FACP, Inc., Diplomate, American Board of Prosthodontics (661) 325-1275 | www.drtupac.com 5060 California Ave., #170, Bakersfield, CA 93309
